Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndrome
Ramya Ramaswami(National Cancer Institute), Robert Yarchoan(National Cancer Institute), Kathryn Lurain(The Ohio State University), Armando Filie(National Institutes of Health), Denise Whitby(Frederick National Laboratory for Cancer Research), Thomas S. Uldrick(Regeneron (United States)), Vickie Marshall(Leidos (United States)), Mark N. Polizzotto(AIDS United), Anaida Widell(AIDS United), Elena Tassi(University of Milan), Irene Ekwede(AIDS United), Elaine S. Jaffe(National Cancer Institute), Hao‐Wei Wang(Fu Jen Catholic University), Stefania Pittaluga(New York University), Mark J. Roth(National Cancer Institute), Adam Rupert(Frederick National Laboratory for Cancer Research)
Cited by 12
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
|Blood|2011|2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k